Seizert Capital Partners »

Biogen Idec shares owned by Seizert Capital Partners

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Seizert Capital Partners from 13F filings

Historical chart of Seizert Capital Partners investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Seizert Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Seizert Capital Partners

Quarter filed Position value Share count Share price at filing
2013-03-31 $205k 1.1k 192.49

More positions owned by Seizert Capital Partners

Acuity Brands (AYI)
Allison Transmission Hldngs I (ALSN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amgen (AMGN)
JPMorgan Chase & Co. (JPM)
Cisco Systems (CSCO)
Goldman Sachs (GS)
NetApp (NTAP)
Anthem (ELV)
LKQ Corporation (LKQ)
Expedia Group Com New (EXPE)
Regeneron Pharmaceuticals (REGN)
Meta Platforms Cl A (META)
Wal-Mart Stores (WMT)
Siriusxm Holdings Common Stock (SIRI)

View all positions for Seizert Capital Partners

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Wellington Management Company
T. Rowe Price Investment Management
Geode Capital Management
Pacer Advisors
T. Rowe Price Associates
Beutel, Goodman & Company
Invesco
Legal & General Group
Northern Trust
RA Capital Management

View all funds holding Biogen Idec